Literature DB >> 12499775

The leukocyte antigen CD43 is expressed in different cell lines of nonhematopoietic origin.

J Fernandez-Rodriguez1, C X Andersson, S Laos, D Baeckström, A Sikut, R Sikut, G C Hansson.   

Abstract

CD43 is an abundant transmembrane sialoglycoprotein in leukocyte-type cell lines, but it has also been suggested to be present in colon adenomas and colon carcinomas. We have now shown that CD43 is expressed in a variety of cell lines of different origins (CaSKI, A549, 293, MTSV1-7, MCF7, HT-1080, Jurkat, K562, COLO 205, HT-29, Caco-2, DLD-1 and SW480). The level of expression of CD43 mRNA was analyzed by reverse transcriptase-polymerase chain reaction and that of the protein by immunoprecipitation and Western blot, flow cytometry and confocal microscopy using two monoclonal anti-CD43 antibodies (L10 and 4D2). As all cell lines expressed CD43, it is suggested that CD43 has a more fundamental function than previously believed and thus cannot be considered only as a specific leukocyte marker. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12499775     DOI: 10.1159/000067252

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  8 in total

1.  Signaling through CD43 regulates CD4 T-cell trafficking.

Authors:  Purvi D Mody; Judy L Cannon; Hozefa S Bandukwala; Kelly M Blaine; Alexander B Schilling; Kevin Swier; Anne I Sperling
Journal:  Blood       Date:  2007-07-16       Impact factor: 22.113

2.  The cleavage of neutrophil leukosialin (CD43) by cathepsin G releases its extracellular domain and triggers its intramembrane proteolysis by presenilin/gamma-secretase.

Authors:  Agnès Mambole; Dominique Baruch; Patrick Nusbaum; Sylvain Bigot; Misa Suzuki; Philippe Lesavre; Minoru Fukuda; Lise Halbwachs-Mecarelli
Journal:  J Biol Chem       Date:  2008-06-27       Impact factor: 5.157

3.  Unraveling the Receptor-Ligand Interactions between Bladder Cancer Cells and the Endothelium Using AFM.

Authors:  Vinoth Sundar Rajan; Valérie M Laurent; Claude Verdier; Alain Duperray
Journal:  Biophys J       Date:  2017-03-28       Impact factor: 4.033

Review 4.  Tumour-reactive B cells and antibody responses after allogeneic haematopoietic cell transplantation.

Authors:  G de Jong; M A Gillissen; H Spits; M D Hazenberg
Journal:  Immunooncol Technol       Date:  2020-07-23

5.  Shedding and gamma-secretase-mediated intramembrane proteolysis of the mucin-type molecule CD43.

Authors:  Christian X Andersson; Julia Fernandez-Rodriguez; Sirle Laos; Dan Baeckström; Christian Haass; Gunnar C Hansson
Journal:  Biochem J       Date:  2005-04-15       Impact factor: 3.857

Review 6.  Aberrant glycosylation as biomarker for cancer: focus on CD43.

Authors:  Franca Maria Tuccillo; Annamaria de Laurentiis; Camillo Palmieri; Giuseppe Fiume; Patrizia Bonelli; Antonella Borrelli; Pierfrancesco Tassone; Iris Scala; Franco Maria Buonaguro; Ileana Quinto; Giuseppe Scala
Journal:  Biomed Res Int       Date:  2014-02-13       Impact factor: 3.411

7.  Intracellular patterns of sialophorin expression define a new molecular classification of breast cancer and represent new targets for therapy.

Authors:  Q Fu; S E Cash; J J Andersen; C R Kennedy; A R Madadi; M Raghavendra; L L Dietrich; W A Agger; C S Shelley
Journal:  Br J Cancer       Date:  2013-11-26       Impact factor: 7.640

8.  CD43 promotes cells transformation by preventing merlin-mediated contact inhibition of growth.

Authors:  Nohemi Camacho-Concha; Amiel Olivos-Ortiz; Alfredo Nuñez-Rivera; Adolfo Pedroza-Saavedra; Lourdes Gutierrez-Xicotencatl; Yvonne Rosenstein; Gustavo Pedraza-Alva
Journal:  PLoS One       Date:  2013-11-18       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.